Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS) SHH

Currency In CNY

AD

Valuation

Market Cap2B
Enterprise Value2.74B
P/E Ratio-14.95
PEG Ratio0.22
Price/Sales Ratio2.61
Price/Book Ratio1.5
Enterprise/Revenue3.28
Enterprise/EBITDA-166.28

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.17
Operating Margin-0.17
AD

Management Effectiveness

Return On Assets-0.06
Return On Equity-0.1

Income Statement

Revenue940.19M
Revenue/Share8.8
Gross Profit222.07M
EBITDA84.1M
Net Income-82.39M
Diluted EPS-0.73

Balance Sheet

Total Cash347.08M
Total Cash/Share3.08
Total Debt921.63M
Total Debt/Equity0.54
Current Ratio1.97
Book Value Per Share15.13

Price History

52-Week Change12.48
52-Week High28.29
52-Week Low13.71
Moving Average 50 Days23.14
Moving Average 200 Days20.88

Statistics

Average Volume6.77M
Shares Outstanding113.62M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.03
Last Split FactorN/A
Last Split DateN/A
AD